Previous PageTable Of Contents


1 Aho K, Ahvonen P, Lassus A, Sievers K, Tiilikainen A.
Yersinia arthritis and related diseases: clinical and imr
munogenetic implications. In: Dumonde D C, ed.
Infection and Immunology in the Rheumatic Diseases.
Oxford: Blackwell, 1976:"341-4. 1 Ebringer R W, Cawdell D R, Cowling P, Ebringer A.
Sequential studies in ankylosing spondylitis: Association
of Klebsiella pneumoniae with active disease. Ann Rheum
Dis 1978;37: 146-51.

3 Ebringer R, Cawdell D, Ebringer A. Klebsiella pneumoniae and acute anterior uveitis in ankylosing spondylitis. Br MedJ 1979: i: 383.
4 Fournier A M, Denizet D, Delagrange A. La lympho-graphie dans la spondylarthrite ankylosante. J Radial Electrol Med Nucl 1969; 50: 773-84.
5 Langness U, Banavsky D, Alexopoulos J, Kriegel W, Burger R. Differentiation of inflammation and ossification in spondylarthritis ankylopoietica. Acta Rheum Scand 1971; 17: 15-22.
6 Veys E M, Van Laere M. Serum IgG, IgM, and IgA levels in ankylosing spondylitis. Ann Rheum Dis 1973; 32: 493-6.
7 Kinsella T D, Espinoza L, Vasey F B. Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis. J Rheumatol 1975; 2: 308-13.
8 Nikbin B, Brewerton D A, Byrom N, et al. Lymphocyte function in ankylosing spondylitis. Ann Rheum bis 1975; 34: 49-54.
9 Lamm M E. Cellular aspects of immunoglobulin A. Adv Immunol 1976; 22: 223-90.
10 Crabbe P A, Nash D R, Bazin M, Eyssen H, Heremans J F. Antibodies of the IgA type in intestinal plasma cells of germ free mice after oral or parenteral immunization with ferritin. / Exp Med 1969; 130: 723^*4.
11 Bennet P H, Wood P H N. In: Bennet P H, Wood P H N. eds. Population Studies of the Rheumatic Diseases. Amsterdam: Excerpta Medica Foundation, 1968; 456.
12 Cowling P, Ebringer R, Cawdell D, Ishii M, Ebringer A. C-reactive protein, ESR, and klebsiella in ankylosing spondylitis. Ann Rheum Dis 1980; 39; 45-9.
13 Jayson M I V, Salmon P R, Harrison W J. Inflammatory bowel disease in ankylosing spondylitis. Gut 1970; 11: 506-11.
14 Wright V. Seronegative polyarthritis: a unified concept. Arthritis Rheum 1978; 21: 619-33.
15 Hadler N M. Granovetter D A. Phlogistic properties of bacterial debris. Semin Arthritis Rheum 1978; 8: 1-16.
16 Ebringer A. The link between genes and disease. A>«' Scientist 1978; 79: 865-7.

17 Ebringer A, Cowling P, Ngwa Sun N, James D C O, Ebringer R W. Crossreactivity between Klebsiella aero-genes species and B27 lymphocyte antigens as an aetio-logical factor in ankylosing spondylitis. Abstract in: Dausset J, Svejgaard A, eds. HLA and Disease. Paris: INSERM, 1976: 27.

18 Seager K. Bashir H V. Geczy A F, Edmonds J, De Vere-Tyndall A. Evidence for a specific B27 associated cell surface marker on lymphocytes of patients with ankylosing spondylitis. Nature 1979; 277: 68-70.

19 Welsh, J Avakian H, Cowling P, el al. Ankylosing spondylitis. HLA-B27 and Klebsiella. I. Crossreactivity studies with rabbit antisera. Br J Exp Pathol 1980; 61: 85-91.

20 Avakian H, Welsh J, Ebringer A, Entwistle C C. Ankylosing spondylitis, HLA B27 and Klebsiella. II. Cross-reactivity studies with human tissue typing sera. Br J Exp Pathol 1980; 61; 92-6.

21 Ebringer A, Doyle A E. Raised serum IgG levels in hypertension. Br MedJ 1970; ii: 146-8.

Previous PageTable Of Contents